240 related articles for article (PubMed ID: 15602032)
21. [Fusion protein abatacept. Remission in every 5th TNF-alpha refractory patient].
MMW Fortschr Med; 2008 Jun; 150(26-27):56-7. PubMed ID: 18683309
[No Abstract] [Full Text] [Related]
22. Early intervention in rheumatoid arthritis.
Vasanth LC; Paget SA
Am J Orthop (Belle Mead NJ); 2007 Jul; 36(7 Suppl):9-10, 15-7. PubMed ID: 17694189
[No Abstract] [Full Text] [Related]
23. Add-on or step-up trials for new drug development in rheumatoid arthritis: a new standard?
Boers M
Arthritis Rheum; 2003 Jun; 48(6):1481-3. PubMed ID: 12794813
[No Abstract] [Full Text] [Related]
24. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
Tijhuis GJ; van de Putte LB; Breedveld FC
Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1880-5. PubMed ID: 11605312
[TBL] [Abstract][Full Text] [Related]
25. A new design for registration trials in rheumatoid arthritis allowing secondary head-to-head comparisons with standard of care treatment including biologicals.
Boers M
Ann Rheum Dis; 2010 Jan; 69(1):4-6. PubMed ID: 20007620
[TBL] [Abstract][Full Text] [Related]
26. Rituximab for the treatment of rheumatoid arthritis.
Schuna AA
Pharmacotherapy; 2007 Dec; 27(12):1702-10. PubMed ID: 18041890
[TBL] [Abstract][Full Text] [Related]
27. Immunization of patients with rheumatoid arthritis with antitumor necrosis factor alpha therapy and methotrexate.
Brezinschek HP; Hofstaetter T; Leeb BF; Haindl P; Graninger WB
Curr Opin Rheumatol; 2008 May; 20(3):295-9. PubMed ID: 18388521
[TBL] [Abstract][Full Text] [Related]
28. Combination sulfasalazine and methotrexate in the management of rheumatoid arthritis.
Shiroky JB
J Rheumatol Suppl; 1996 Mar; 44():69-71. PubMed ID: 8833057
[TBL] [Abstract][Full Text] [Related]
29. [Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society].
Salvarani C; Olivieri I; Cantini F; Marchesoni A; Punzi L; Scarpa R; Matucci-Cerinic M
Reumatismo; 2004; 56(3):133-4, 136-8. PubMed ID: 15470517
[No Abstract] [Full Text] [Related]
30. Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.
van Oosterhout M; Levarht EW; Sont JK; Huizinga TW; Toes RE; van Laar JM
Ann Rheum Dis; 2005 Apr; 64(4):537-43. PubMed ID: 15769913
[TBL] [Abstract][Full Text] [Related]
31. [When to begin rheumatism treatment? Initial combination therapy helps fastest].
Fath R
MMW Fortschr Med; 2004 Sep; 146(37):5-6. PubMed ID: 15887691
[No Abstract] [Full Text] [Related]
32. [Juvenile rheumatoid arthritis].
Honkanen V; Lahdenne P
Duodecim; 2000; 116(8):839-43. PubMed ID: 11787127
[No Abstract] [Full Text] [Related]
33. [Basic therapeutic and immunosuppressive drugs in rheumatoid arthritis. No fear of "heavy weapons"].
Krüger K
MMW Fortschr Med; 2002 Aug; 144(33-34):25-30. PubMed ID: 12380140
[No Abstract] [Full Text] [Related]
34. Cutaneous mucormycosis complicating methotrexate, prednisone, and infliximab therapy.
Gadadhar H; Hawkins S; Huffstutter JE; Panda M
J Clin Rheumatol; 2007 Dec; 13(6):361-2. PubMed ID: 18176152
[No Abstract] [Full Text] [Related]
35. Update on rituximab.
Eisenberg R
Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv55-7. PubMed ID: 16239389
[No Abstract] [Full Text] [Related]
36. How is it best to treat early rheumatoid arthritis patients?
O'Dell JR
Best Pract Res Clin Rheumatol; 2001 Mar; 15(1):125-37. PubMed ID: 11358419
[TBL] [Abstract][Full Text] [Related]
37. Etanercept in rheumatoid arthritis.
Cook DA; Dimick JB; Gallagher DC
N Engl J Med; 1999 Jun; 340(25):2000; author reply 2001. PubMed ID: 10383273
[No Abstract] [Full Text] [Related]
38. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
[No Abstract] [Full Text] [Related]
39. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
Schnabel A; Gross WL
Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
[No Abstract] [Full Text] [Related]
40. Systemic nocardiosis in a case of rheumatoid arthritis treated with tumor necrosis factor blockers.
Wendling D; Murad M; Mathieu S; Berger E; Rumbach L
J Rheumatol; 2008 Mar; 35(3):539-42. PubMed ID: 18322977
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
